Patents by Inventor Christelle NONNE

Christelle NONNE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TRPA1 ANTAGONISTS FOR USE IN THE TREATMENT OF ATOPIC DERMATITIS
    Publication number: 20200390774
    Abstract: The present invention relates to a TRPA1 receptor antagonist for use in preventing and/or treating the inflammatory component of atopic dermatitis.
    Type: Application
    Filed: August 26, 2020
    Publication date: December 17, 2020
    Inventors: Gilles OUVRY, Feriel HACINI-RACHINEL, Christelle NONNE
  • TRPA1 ANTAGONISTS FOR USE IN THE TREATMENT OF ATOPIC DERMATITIS
    Publication number: 20190307758
    Abstract: The present invention relates to a TRPA1 receptor antagonist for use in preventing and/or treating the inflammatory component of atopic dermatitis.
    Type: Application
    Filed: June 13, 2019
    Publication date: October 10, 2019
    Inventors: Gilles OUVRY, Feriel HACINI-RACHINEL, Christelle NONNE
  • CGRP RECEPTOR ANTAGONIST COMPOUNDS FOR TOPICAL TREATMENT OF SKIN DISORDERS
    Publication number: 20180185360
    Abstract: The use of a CGRP receptor antagonist compound of formula (I) for topical application is described for treating and/or preventing skin inflammatory pathologies with a neurogenic component. More specifically, use of a CGRP receptor antagonist compound of formula (I) is described for topical application for treating and/or preventing rosacea, especially type I rosacea, atopic dermatitis, psoriasis and/or acne.
    Type: Application
    Filed: June 28, 2016
    Publication date: July 5, 2018
    Inventors: Christelle NONNE, Michel RIVIER, Patricia ROSSIO, Feriel HACINI-RACHINEL
  • METHOD FOR TREATING CELL PROLIFERATION DISORDERS
    Publication number: 20150313896
    Abstract: Methods, compositions and products for treating or reducing a cell proliferation disorder, such as hand and foot syndrome or cutaneous T cell lymphoma, in a subject in need thereof are described. The methods involve topically administering to the subject a composition containing an ? adrenergic receptor agonist, such as brimonidine.
    Type: Application
    Filed: July 14, 2015
    Publication date: November 5, 2015
    Inventors: Guy BOUVIER, Carine ROSIGNOLI, Christelle NONNE, Emmanuel VIAL